Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05261516Phase 4Recruiting

Interaction of Volatile Anesthetics With Magnesium

Role: lead

NCT03497923Phase 4Completed

Interaction Between Magnesium and Neostigmine or Sugammadex for the Reversal of a Rocuronium-induced Neuromuscular Block

Role: lead

NCT03649672Not ApplicableTerminated

The Validity and Tolerability of Awake Calibration of the TOF Watch SX Monitor

Role: lead

NCT03256955Not ApplicableCompleted

Validation of the TOF Cuff Monitor® Which Measures Neuromuscular Block on the Upper Arm

Role: lead

All 4 trials loaded